beta-Catenin mutations in cell lines established from human colorectal cancers

被引:435
|
作者
Ilyas, M
Tomlinson, IPM
Rowan, A
Pignatelli, M
Bodmer, WF
机构
[1] ROYAL MARSDEN HOSP, CANC RES INST, HADDOW LABS, SUTTON SH2 5NG, SURREY, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT PATHOL, LONDON W12 0HS, ENGLAND
关键词
sequencing; CTNNB1; intestinal cancer;
D O I
10.1073/pnas.94.19.10330
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta-catenin has functions as both an adhesion and a signaling molecule, Disruption of these functions through mutations of the beta-catenin gene (CTNNB1) may be important in the development of colorectal tumors, We examined the entire coding sequence of beta-catenin by reverse transcriptase-PCR (RT-PCR) and direct sequencing of 23 human colorectal cancer cell lines from 21 patients, In two cell lines, there was apparent instability of the beta-catenin mRNA. Five different mutations (26%) were found in the remaining 21cell lines (from 19 patients), A three-base deletion (codon 45) was identified in the cell line HCT 116, whereas cell lines SW 48, HCA 46, CACO 2, and Cole 201 each contained single-base missense mutations (codons 33, 183, 245, and 287, respectively), All 23 cell lines had full-length beta-catenin protein that was detectable by Western blotting and that coprecipitated with E-cadherin, In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable. In SW48 and HCA 46, however, we did not detect complexes of beta-catenin protein with alpha-catenin and APC, respectively, These results show that selection of CTNNB1 mutations occurs in up to 26% of colorectal cancers from which cell lines are derived. In these cases, mutation selection is probably for altered beta-catenin function, which may significantly alter intracellular signaling and intercellular adhesion and may serve as a complement to APC mutations in the early stages of tumorigenesis.
引用
收藏
页码:10330 / 10334
页数:5
相关论文
共 50 条
  • [31] PROPERTIES OF CELL LINES ESTABLISHED FROM TRANSITIONAL CELL CANCERS OF HUMAN URINARY-TRACT
    ELLIOTT, AY
    BRONSON, DL
    CERVENKA, J
    STEIN, N
    FRALEY, EE
    CANCER RESEARCH, 1977, 37 (05) : 1279 - 1289
  • [32] CHARACTERISTICS OF CELL-LINES ESTABLISHED FROM HUMAN COLORECTAL-CARCINOMA
    PARK, JG
    OIE, HK
    SUGARBAKER, PH
    HENSLEE, JG
    CHEN, TR
    JOHNSON, BE
    GAZDAR, A
    CANCER RESEARCH, 1987, 47 (24) : 6710 - 6718
  • [33] BETA(2)-MICROGLOBULIN GENE-MUTATIONS - A STUDY OF ESTABLISHED COLORECTAL CELL-LINES AND FRESH TUMORS
    BICKNELL, DC
    ROWAN, A
    BODMER, WF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4751 - 4755
  • [34] Effects of prebiotic Quercetin on proliferation and beta-catenin expression in colon cancer cell lines
    Marzo, Florencio
    Alfaro, Maria
    Jauregui, Patricia
    Benito, Ivan
    Santidrian, Santiago
    Urdaneta, Elena
    FASEB JOURNAL, 2009, 23
  • [35] Characterization of cancer cell lines established from two human metastatic breast cancers
    Nayak, SK
    Kakati, S
    Harvey, SR
    Malone, CC
    Cornforth, AN
    Dillman, RO
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2000, 36 (03) : 188 - 193
  • [36] Characterization of cancer cell lines established from two human metastatic breast cancers
    Shankar K. Nayak
    Surabhi Kakati
    Shashi R. Harvey
    Colin C. Malone
    Andrew N. Cornforth
    Robert O. Dillman
    In Vitro Cellular & Developmental Biology - Animal, 2000, 36 (3) : 188 - 193
  • [37] Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors
    Kitaeva, MN
    Grogan, L
    Williams, JP
    Dimond, E
    Nakahara, K
    Hausner, P
    DeNobile, JW
    Soballe, PW
    Kirsh, IR
    CANCER RESEARCH, 1997, 57 (20) : 4478 - 4481
  • [38] Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis
    Miller, Dylan V.
    Wang, Huamin
    Wang, Hua
    Fealey, Michael E.
    Tazelaar, Henry D.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2008, 11 (04) : 291 - 294
  • [39] Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
    Saifo, Maher S.
    Rempinski, Donald R., Jr.
    Rustum, Youcef M.
    Azrak, Rami G.
    MOLECULAR CANCER, 2010, 9
  • [40] Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
    Maher S Saifo
    Donald R Rempinski
    Youcef M Rustum
    Rami G Azrak
    Molecular Cancer, 9